Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice
Timothy W. Lefever, Julie A. Marusich, Brian F. Thomas, et al.
Substance Abuse Research and Treatment (2017) Vol. 11
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

New psychoactive substances: a review and updates
Abu Shafi, Alex J. Berry, Harry Sumnall, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 246
The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review
Vera L. Alves, João Gonçalves, Joselin Aguiar, et al.
Critical Reviews in Toxicology (2020) Vol. 50, Iss. 5, pp. 359-382
Closed Access | Times Cited: 156
Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts
Thivanka Muthumalage, Irfan Rahman
Toxicology and Applied Pharmacology (2019) Vol. 382, pp. 114713-114713
Open Access | Times Cited: 107
Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
Arianna Giorgetti, Francesco Paolo Busardò, Roberta Tittarelli, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 104
An Update on the Implications of New Psychoactive Substances in Public Health
Ana Y. Simão, Mónica Antunes, Emanuel Cabral, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4869-4869
Open Access | Times Cited: 39
The chemistry and toxicology of vaping
Emily M. Bonner, Yvonne Chang, Emerson Christie, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107837-107837
Open Access | Times Cited: 55
Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats
Jacques D. Nguyen, Yanabel Grant, Tony M. Kerr, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 172, pp. 33-38
Open Access | Times Cited: 54
The Association between Cannabis Product Characteristics and Symptom Relief
Sarah S. Stith, Jacob M. Vigil, Franco Brockelman, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 50
The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report)
Vincenzo Abbate, Michael Schwenk, Brandon C. Presley, et al.
Pure and Applied Chemistry (2018) Vol. 90, Iss. 8, pp. 1255-1282
Open Access | Times Cited: 44
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications
Carolina Lobato-Freitas, Andreia Machado Brito-da-Costa, Ricardo Jorge Dinis‐Oliveira, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 186-186
Open Access | Times Cited: 28
New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions
Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-36
Open Access | Times Cited: 11
New psychoactive substances: Pharmacology and impact on human health
Rebeca Vidal, Ma Esther O’Shea Gaya, M López, et al.
Comprehensive analytical chemistry (2025)
Closed Access
Effects of Δ⁹-tetrahydrocannabinol (THC) vapor inhalation in Sprague-Dawley and Wistar rats.
Michael A. Taffe, Kevin M. Creehan, Sophia A. Vandewater, et al.
Experimental and Clinical Psychopharmacology (2020) Vol. 29, Iss. 1, pp. 1-13
Open Access | Times Cited: 31
Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures
Richard C. Kevin, Alexander L. Kovach, Timothy W. Lefever, et al.
Forensic Toxicology (2018) Vol. 37, Iss. 1, pp. 17-26
Open Access | Times Cited: 32
Do you feel it now? Route of administration and Δ9-tetrahydrocannabinol-like discriminative stimulus effects of synthetic cannabinoids in mice
Jenny L. Wiley, Timothy W. Lefever, Michelle Glass, et al.
NeuroToxicology (2019) Vol. 73, pp. 161-167
Open Access | Times Cited: 27
Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems
Cristina Miliano, E. Reilly Scott, Laura B. Murdaugh, et al.
Journal of Neuroscience Methods (2019) Vol. 330, pp. 108458-108458
Open Access | Times Cited: 27
Enhancing effects of acute exposure to cannabis smoke on working memory performance
Shelby L. Blaes, Caitlin A. Orsini, Hannah M. Holik, et al.
Neurobiology of Learning and Memory (2018) Vol. 157, pp. 151-162
Open Access | Times Cited: 24
Route of administration effects on nicotine discrimination in female and male mice
Timothy W. Lefever, Brian F. Thomas, Alexander L. Kovach, et al.
Drug and Alcohol Dependence (2019) Vol. 204, pp. 107504-107504
Open Access | Times Cited: 20
Explication of CB1 receptor contributions to the hypothermic effects of Δ9-tetrahydrocannabinol (THC) when delivered by vapor inhalation or parenteral injection in rats
Jacques D. Nguyen, Kevin M. Creehan, Yanabel Grant, et al.
Drug and Alcohol Dependence (2020) Vol. 214, pp. 108166-108166
Open Access | Times Cited: 20
Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats
Jérémy Carlier, Ariane Wohlfarth, Bonita Salmerón, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 367, Iss. 3, pp. 543-550
Open Access | Times Cited: 18
Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures
Vera L. Alves, João Gonçalves, Joselin Aguiar, et al.
Analytical and Bioanalytical Chemistry (2021) Vol. 413, Iss. 8, pp. 2257-2273
Closed Access | Times Cited: 13
Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists
Matilda Houston, Jody Morgan, Céline Kelso
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 92-109
Closed Access | Times Cited: 5
Toxic effects of AB-CHMINACA on liver and kidney and detection of its blood level in adult male mice
Soheir Mohammad, Rasha Elhaddad Ali Mousa, Sahar M. Gebril, et al.
Forensic Toxicology (2023) Vol. 42, Iss. 1, pp. 7-17
Open Access | Times Cited: 5
Evidence for public health on novel psychoactive substance use: a mixed-methods study
Kathryn Higgins, Nina O’Neill, Leeanne O’Hara, et al.
Public Health Research (2019) Vol. 7, Iss. 14, pp. 1-150
Open Access | Times Cited: 15
Broadly Neutralizing Synthetic Cannabinoid Vaccines
Mingliang Lin, Jinny Claire Lee, Steven Blake, et al.
JACS Au (2020) Vol. 1, Iss. 1, pp. 31-40
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top